{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:02:12Z","timestamp":1790676132330,"version":"4.1.0"},"reference-count":70,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM088129"],"award-info":[{"award-number":["T32GM088129"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["F31DE026682"],"award-info":[{"award-number":["F31DE026682"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["2014-6696"],"award-info":[{"award-number":["2014-6696"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["2014-6696"],"award-info":[{"award-number":["2014-6696"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swim Across America","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR160027"],"award-info":[{"award-number":["RR160027"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR160027"],"award-info":[{"award-number":["RR160027"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"McNair Medical Institute at The Robert and Janice McNair Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"McNair Medical Institute at The Robert and Janice McNair Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Cancer Research Institute Team Strategy Grant","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01DE028233-01"],"award-info":[{"award-number":["1U01DE028233-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Caroline Weiss Law Endowment","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Owens Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-018-0485-9","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T12:02:44Z","timestamp":1547553764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-7183","authenticated-orcid":false,"given":"Aurelie","family":"Hanoteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Krupar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Gaspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn D.","family":"Gartrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia J.","family":"Santegoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damya","family":"Laoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Spanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd H.","family":"Van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo A.","family":"Van Ginderachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. M.","family":"Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"issue":"12","key":"485_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"8","key":"485_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. Aug. 2010;11(8):781\u20139.","journal-title":"Lancet Oncol"},{"issue":"12","key":"485_CR3","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","volume":"15","author":"C Ndiaye","year":"2014","unstructured":"Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagu\u00e9 X, Laporte L, Bosch FX, de Sanjos\u00e9 S, Trottier H. HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319\u201331.","journal-title":"Lancet Oncol"},{"issue":"1","key":"485_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/1097-0215(20001001)88:1<92::AID-IJC15>3.0.CO;2-E","volume":"88","author":"HJ Bontkes","year":"2000","unstructured":"Bontkes HJ, de Gruijl TD, van den Muysenberg AJC, Verheijen RHM, Stukart MJ, Meijer CJLM, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JMM. Human papillomavirus type 16 E6\/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. Int J Cancer. 2000;88(1):92\u20138.","journal-title":"Int J Cancer"},{"issue":"12","key":"485_CR5","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","volume":"27","author":"P Lassen","year":"2009","unstructured":"Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992\u20138.","journal-title":"J Clin Oncol"},{"issue":"11","key":"485_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archoto.2009.159","volume":"135","author":"WC Spanos","year":"2009","unstructured":"Spanos WC, Nowicki P, Lee D, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus\u2013related head and neck cancer. Arch Otolaryngol Neck Surg. 2009;135(11):1137\u201346.","journal-title":"Arch Otolaryngol Neck Surg"},{"key":"485_CR7","doi-asserted-by":"crossref","unstructured":"S. Braunstein and J. L. Nakamura, \u201cRadiotherapy-induced malignancies : review of clinical features, pathobiology, and evolving approaches for mitigating risk,\u201d Front. Oncol, vol. 3, no. April, pp. 1\u201315, 2013.","DOI":"10.3389\/fonc.2013.00073"},{"issue":"1","key":"485_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.oraloncology.2012.07.015","volume":"49","author":"SH Huang","year":"2013","unstructured":"Huang SH, Perez-Ordonez B, Weinreb I, Hope A, Massey C, Waldron JN, Kim J, Bayley AJ, Cummings B, John Cho BC, Ringash J, Dawson LA, Siu LL, Chen E, Irish J, Gullane P, Hui A, Liu FF, Shen X, Xu W, O\u2019Sullivan B. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 2013;49(1):79\u201385.","journal-title":"Oral Oncol"},{"issue":"2","key":"485_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/bjc.2016.166","volume":"115","author":"V Sridharan","year":"2016","unstructured":"Sridharan V, Margalit DN, Lynch SA, Severgnini M, Zhou J, Chau NG, Rabinowits G, Lorch JH, Hammerman PS, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD. Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer. Br J Cancer. 2016;115(2):252\u201360.","journal-title":"Br J Cancer"},{"issue":"7","key":"485_CR10","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","volume":"71","author":"BC Burnette","year":"2011","unstructured":"Burnette BC, Liang H, Lee Y, Chlewicki L, Khodarev NN, Weichselbaum RR, Fu Y-X, Auh SL. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. Apr. 2011;71(7):2488\u201396.","journal-title":"Cancer Res"},{"issue":"5","key":"485_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.20052494","volume":"203","author":"EA Reits","year":"2006","unstructured":"Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259\u201371.","journal-title":"J Exp Med"},{"issue":"23","key":"485_CR12","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1158\/1078-0432.CCR-13-0900","volume":"19","author":"PJ Schuler","year":"2013","unstructured":"Schuler PJ, Harasymczuk M, Schilling B, Saze Z, Strauss L, Lang S, Johnson JT, Whiteside TL. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer. Clin Cancer Res. 2013;19(23):6585\u201396.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"485_CR13","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00262-013-1488-5","volume":"62","author":"S Al-Taei","year":"2013","unstructured":"Al-Taei S, Banner R, Powell N, Evans M, Palaniappan N, Tabi Z, Man S. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunol Immunother. Dec. 2013;62(12):1821\u201330.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"485_CR14","doi-asserted-by":"publisher","first-page":"e1267095","DOI":"10.1080\/2162402X.2016.1267095","volume":"6","author":"H Meir van","year":"2017","unstructured":"van Meir H, Nout RA, Welters MJP, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJM, Burggraaf J, van Poelgeest MIE, van der Burg SH. Impact of (chemo) radiotherapy on immune cell composition and function in cervical cancer patients. Oncoimmunology. 2017;6(2):e1267095.","journal-title":"Oncoimmunology"},{"issue":"3","key":"485_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1054\/bjom.2001.0680","volume":"40","author":"PA Brennan","year":"2002","unstructured":"Brennan PA, Umar T, Smith GI, Lo CH, Tant S. Expression of nitric oxide synthase-2 in cutaneous squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg. 2002;40(3):191\u20134.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"Suppl 1","key":"485_CR16","first-page":"2443 LP-2443","volume":"130","author":"R Jacamo","year":"2017","unstructured":"Jacamo R, Hoang N-M, Al Rawi A, Ly C, Parihar R, McQueen T, Ruvolo PP, Williams P, Alatrash G, Konopleva M, Andreeff M. Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype. Blood. 2017;130(Suppl 1):2443 LP-2443.","journal-title":"Blood"},{"issue":"11","key":"485_CR17","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.4049\/jimmunol.1103553","volume":"188","author":"P Jayaraman","year":"2012","unstructured":"Jayaraman P, Parikh F, Lopez-Rivera E, Hailemichael Y, Clark A, Ma G, Cannan D, Ramacher M, Kato M, Overwijk WW, Chen SH, Umansky VY, Sikora AG. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol. 2012;188(11):5365\u201376.","journal-title":"J Immunol"},{"issue":"23","key":"485_CR18","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1021\/jm00049a007","volume":"37","author":"WM Moore","year":"1994","unstructured":"Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG. L-N6-(1-Iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 1994;37(23):3886\u20138.","journal-title":"J Med Chem"},{"issue":"10","key":"485_CR19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1096\/fj.02-0633fje","volume":"17","author":"TT Hansel","year":"2003","unstructured":"Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J. Jul. 2003;17(10):1298\u2013300.","journal-title":"FASEB J"},{"issue":"24","key":"485_CR20","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1158\/1078-0432.CCR-13-3409","volume":"20","author":"P Jayaraman","year":"2014","unstructured":"Jayaraman P, Alfarano MG, Svider PF, Parikh F, Lu G, Kidwai S, Xiong H, Sikora AG. iNOS expression in CD4+ T cells limits treg induction by repressing TGF\u03b21: combined iNOS inhibition and treg depletion unmask endogenous antitumor immunity. Clin Cancer Res. 2014;20(24):6439\u201351.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"485_CR21","first-page":"1649","volume":"49","author":"M Awwad","year":"1989","unstructured":"Awwad M, North RJ. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res. 1989;49(7):1649\u201354.","journal-title":"Cancer Res"},{"issue":"12","key":"485_CR22","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1002\/ijc.28617","volume":"134","author":"G Rahir","year":"2014","unstructured":"Rahir G, Wathelet N, Hanoteau A, Henin C, Oldenhove G, Galuppo A, Lanaya H, Colau D, Mackay CR, Van Den Eynde B, Moser M. Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E\/H-2Kd-specific CD8+ T cells. Int J Cancer. 2014;134(12):2841\u201352.","journal-title":"Int J Cancer"},{"key":"485_CR23","doi-asserted-by":"crossref","unstructured":"Hanoteau A, Henin C, Svec D, Bisilliat Donnet C, Denanglaire S, Colau D, Romero P, Leo O, Van den Eynde B, Moser M. Cyclophosphamide treatment regulates the balance of functional\/exhausted tumor-specific CD8+T cells. Oncoimmunology. 2017;6(8).","DOI":"10.1080\/2162402X.2017.1318234"},{"issue":"22","key":"485_CR24","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","volume":"23","author":"M Scurr","year":"2017","unstructured":"Scurr M, Pembroke T, Bloom A, Roberts D, Thomson A, Smart K, Bridgeman H, Adams R, Brewster A, Jones R, Gwynne S, Blount D, Harrop R, Hills R, Gallimore A, Godkin A. Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer. Clin Cancer Res. 2017;23(22):6771\u201380.","journal-title":"Clin Cancer Res"},{"key":"485_CR25","doi-asserted-by":"crossref","unstructured":"Vermeer DW, Coppock JD, Zeng E, Lee KM, Spanos WC, Onken MD, Uppaluri R, Lee JH, Vermeer PD. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7(17).","DOI":"10.18632\/oncotarget.8254"},{"key":"485_CR26","doi-asserted-by":"crossref","unstructured":"Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, Anderson ME, Lee JH. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009;135(11):1137\u201346.","DOI":"10.1001\/archoto.2009.159"},{"issue":"3","key":"485_CR27","doi-asserted-by":"publisher","first-page":"674 LP-683","DOI":"10.1158\/1078-0432.CCR-17-0866","volume":"24","author":"MK Chung","year":"2018","unstructured":"Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB. CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug. Clin. Cancer Res. 2018;24(3):674 LP-683.","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"485_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1158\/1078-0432.CCR-17-2140","volume":"24","author":"MJP Welters","year":"2017","unstructured":"Welters MJP, Ma W, Santegoets SJAM, Goedemans R, Ehsan I, Jordanova ES, Van Ham VJ, Van Unen V, Koning F, Van Egmond SI, Charoentong P, Trajanoski Z, Van Der Velden LA, Van Der Burg SH. Intratumoral HPV16-specific T cells constitute a type I\u2013oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer. Clin Cancer Res. 2017;24(3):634\u201347.","journal-title":"Clin Cancer Res"},{"key":"485_CR29","first-page":"clincanres.1749","volume":"2018","author":"SJ Santegoets","year":"2018","unstructured":"Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, Duurland CL, van Unen V, H\u00f6llt T, van der Velden L-A, van Egmond SI, Kortekaas K, de Vos van Steenwijk PJ, van Poelgeest MI, Welters MJP, van der Burg SH. The anatomical location shapes the immune infiltrate in tumors of same etiology and impacts survival. Clin. Cancer Res. 2018;2018:clincanres.1749.","journal-title":"Clin. Cancer Res"},{"key":"485_CR30","doi-asserted-by":"publisher","unstructured":"Newton JM, Hanoteau A, Sikora AG. Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors. J Vis Exp. 2018;136. https:\/\/doi.org\/10.3791\/57685 .","DOI":"10.3791\/57685"},{"issue":"4","key":"485_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/2326-6066.CIR-17-0360","volume":"6","author":"RD Gartrell","year":"2018","unstructured":"Gartrell RD, Marks DK, Hart TD, Li G, Davari DR, Wu A, Blake Z, Lu Y, Askin KN, Monod A, Esancy CL, Stack EC, Jia DT, Armenta PM, Fu Y, Izaki D, Taback B, Rabadan R, Kaufman HL, Drake CG, Horst BA, Saenger YM. Quantitative Analysis of Immune Infiltrates in Primary Melanoma. Cancer Immunol Res. 2018;6(4):481\u201393.","journal-title":"Cancer Immunol Res"},{"key":"485_CR32","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3389\/fimmu.2017.02004","volume":"8","author":"T Kitamura","year":"2018","unstructured":"Kitamura T, Doughty-Shenton D, Cassetta L, Fragkogianni S, Brownlie D, Kato Y, Carragher N, Pollard JW. Monocytes differentiate to immune suppressive precursors of metastasis-associated macrophages in mouse models of metastatic breast cancer. Front. Immunol. 2018;8:2004.","journal-title":"Front. Immunol"},{"issue":"8","key":"485_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/bjc.2014.446","volume":"111","author":"P Balermpas","year":"2014","unstructured":"Balermpas P, R\u00f6del F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S, Harter PN, Mittelbronn M, Weiss C, R\u00f6del C, Fokas E. Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences. Br J Cancer. 2014;111(8):1509\u201318.","journal-title":"Br J Cancer"},{"key":"485_CR34","doi-asserted-by":"crossref","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpe\u00f1o J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, \u00d6zg\u00fcro\u011flu M. Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2017;377:1919-1929.","DOI":"10.1056\/NEJMoa1709937"},{"issue":"1","key":"485_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imm.12913","volume":"154","author":"E Hughes","year":"2018","unstructured":"Hughes E, Scurr M, Campbell E, Jones E, Godkin A, Gallimore A. T-cell modulation by cyclophosphamide for tumour therapy. Immunology. 2018;154(1):62\u20138.","journal-title":"Immunology"},{"key":"485_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gdata.2014.11.006","volume":"3","author":"V Chalivendra","year":"2015","unstructured":"Chalivendra V, Kanchi KL, Onken MD, Winkler AE, Mardis E, Uppaluri R. Genomic analysis to define molecular basis of aggressiveness in a mouse model of oral cancer. Genomics Data. 2015;3:61\u20132.","journal-title":"Genomics Data"},{"issue":"14","key":"485_CR37","doi-asserted-by":"publisher","first-page":"5728 LP-5739","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi K, Laoui D, Gysemans C, Baeten M, Stang\u00e9 G, Van den Bossche J, Mack M, Pipeleers D, In\u2019t Veld P, De Baetselier P, Van Ginderachter JA. Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes. Cancer Res. 2010;70(14):5728 LP-5739.","journal-title":"Cancer Res"},{"issue":"11","key":"485_CR38","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.4049\/jimmunol.1602077","volume":"198","author":"NV Acuff","year":"2017","unstructured":"Acuff NV, Linden J. Using visualization of t-distributed stochastic neighbor embedding to identify immune cell subsets in mouse tumors. J Immunol. Mar. 2017;198(11):4539\u201346.","journal-title":"J Immunol"},{"key":"485_CR39","doi-asserted-by":"crossref","unstructured":"S. Kuhn, J. Yang, and F. Ronchese, \u201cMonocyte-derived dendritic cells are essential for CD8+ T cell activation and antitumor responses after local immunotherapy,\u201d Front Immunol., vol. 6, no. NOV, pp. 1\u201314, 2015.","DOI":"10.3389\/fimmu.2015.00584"},{"issue":"7","key":"485_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrc.2016.54","volume":"16","author":"C Engblom","year":"2016","unstructured":"Engblom C, Pfirschke C, Pittet MJ. The role of myeloid cells in cancer therapies. Nat Rev Cancer. 2016;16(7):447\u201362.","journal-title":"Nat Rev Cancer"},{"key":"485_CR41","doi-asserted-by":"crossref","unstructured":"L. Apetoh, M. J. Smyth, C. G. Drake, J.-P. Abastado, R. N. Apte, M. Ayyoub, J.-Y. Blay, M. Bonneville, L. H. Butterfield, A. Caignard, C. Castelli, F. Cavallo, E. Celis, L. Chen, M. P. Colombo, B. Comin-Anduix, G. Coukos, M. V. Dhodapkar, G. Dranoff, I. H. Frazer, W.-H. Fridman, D. I. Gabrilovich, E. Gilboa, S. Gnjatic, D. J\u00e4ger, P. Kalinski, H. L. Kaufman, R. Kiessling, J. Kirkwood, A. Knuth, R. Liblau, M. T. Lotze, E. Lugli, F. Marincola, I. Melero, C. J. Melief, T. R. Mempel, E. A. Mittendorf, K. Odun, W. W. Overwijk, A. K. Palucka, G. Parmiani, A. Ribas, P. Romero, R. D. Schreiber, G. Schuler, P. K. Srivastava, E. Tartour, D. Valmori, S. H. van der Burg, P. van der Bruggen, B. J. van den Eynde, E. Wang, W. Zou, T. L. Whiteside, D. E. Speiser, D. M. Pardoll, N. P. Restifo, and A. C. Anderson, \u201cConsensus nomenclature for CD8+ T cell phenotypes in cancer,\u201d Oncoimmunology, vol. 4, no. 4, p. e998538, Apr. 2015.","DOI":"10.1080\/2162402X.2014.998538"},{"issue":"4","key":"485_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","volume":"48","author":"D Herndler-Brandstetter","year":"2018","unstructured":"Herndler-Brandstetter D, Ishigame H, Shinnakasu R, Plajer V, Stecher C, Zhao J, Lietzenmayer M, Kroehling L, Takumi A, Kometani K, Inoue T, Kluger Y, Kaech SM, Kurosaki T, Okada T, Flavell RA. KLRG1+Effector CD8+T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity. Immunity. 2018;48(4):716\u2013729.e8.","journal-title":"Immunity"},{"issue":"1","key":"485_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2567.2009.03072.x","volume":"128","author":"A Meiraz","year":"2009","unstructured":"Meiraz A, Garber OG, Harari S, Hassin D, Berke G. Switch from perforin-expressing to perforin-deficient CD8+ T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo. Immunology. 2009;128(1):69\u201382.","journal-title":"Immunology"},{"issue":"13","key":"485_CR44","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1158\/0008-5472.CAN-04-1032","volume":"64","author":"SL Lu","year":"2004","unstructured":"Lu SL, Reh D, Li AG, Woods J, Corless CL, Kulesz-Martin M, Wang XJ. Overexpression of transforming growth factor \u03b21 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 2004;64(13):4405\u201310.","journal-title":"Cancer Res"},{"issue":"5","key":"485_CR45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cyto.2003.11.005","volume":"25","author":"DM Lathers","year":"2004","unstructured":"Lathers DM, Young MRI. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine. Mar. 2004;25(5):220\u20138.","journal-title":"Cytokine"},{"key":"485_CR46","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Th\u00e9ate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. Sep. 2003;9:1269.","journal-title":"Nat Med"},{"key":"485_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.oraloncology.2016.05.002","volume":"58","author":"RJ Davis","year":"2016","unstructured":"Davis RJ, Van Waes C, Allen CT. Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. Oral Oncol. 2016;58:59\u201370.","journal-title":"Oral Oncol"},{"issue":"3","key":"485_CR48","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1501293","volume":"196","author":"RH Younis","year":"2016","unstructured":"Younis RH, Han KL, Webb TJ. Human head and neck squamous cell carcinoma\u2013associated Semaphorin 4D induces expansion of myeloid-derived suppressor cells. J Immunol. 2016;196(3):1419\u201329.","journal-title":"J Immunol"},{"key":"485_CR49","doi-asserted-by":"crossref","unstructured":"Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends in Immunology. 2003;6:302-6.","DOI":"10.1016\/S1471-4906(03)00132-7"},{"issue":"11","key":"485_CR50","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1158\/0008-5472.CAN-16-2238","volume":"77","author":"PS Redd","year":"2017","unstructured":"Redd PS, Ibrahim ML, Klement JD, Sharman SK, Paschall AV, Yang D, Nayak-Kapoor A, Liu K. SETD1B activates iNOS expression in myeloid-derived suppressor cells. Cancer Res. 2017;77(11):2834\u201343.","journal-title":"Cancer Res"},{"issue":"1","key":"485_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol. 2006;16(1):53\u201365.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"485_CR52","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3109\/10715762.2014.957694","volume":"48","author":"T Matsunaga","year":"2014","unstructured":"Matsunaga T, Yamaji Y, Tomokuni T, Morita H, Morikawa Y, Suzuki A, Yonezawa A, Endo S, Ikari A, Iguchi K, El-Kabbani O, Tajima K, Hara A. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome. Free Radic Res. Nov. 2014;48(11):1371\u201385.","journal-title":"Free Radic Res"},{"issue":"12","key":"485_CR53","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/j.1349-7006.2011.02095.x","volume":"102","author":"W Saleem","year":"2011","unstructured":"Saleem W, Suzuki Y, Mobaraki A, Yoshida Y, Noda S, Saitoh JI, Nakano T. Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer. Cancer Sci. 2011;102(12):2150\u20136.","journal-title":"Cancer Sci"},{"issue":"5","key":"485_CR54","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.ijrobp.2009.10.014","volume":"76","author":"A Battaglia","year":"2010","unstructured":"Battaglia A, Buzzonetti A, Martinelli E, Fanelli M, Petrillo M, Ferrandina G, Scambia G, Fattorossi A. Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant Chemoradiation regimens for locally advanced cervical Cancer. Int J Radiat Oncol Biol Phys. 2010;76(5):1546\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"485_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fimmu.2017.00231","volume":"8","author":"B Frey","year":"2017","unstructured":"Frey B, R\u00fcckert M, Weber J, Mayr X, Derer A, Lotter M, Bert C, R\u00f6del F, Fietkau R, Gaipl US. Hypofractionated irradiation has immune stimulatory potential and induces a timely restricted infiltration of immune cells in Colon Cancer tumors. Front Immunol. 2017;8:231.","journal-title":"Front Immunol"},{"issue":"16","key":"485_CR56","doi-asserted-by":"publisher","first-page":"4673 LP-4683","DOI":"10.1158\/0008-5472.CAN-15-3451","volume":"76","author":"M Hettich","year":"2016","unstructured":"Hettich M, Lahoti J, Prasad S, Niedermann G. Checkpoint Antibodies but not T Cell\u2013Recruiting Diabodies Effectively Synergize with TIL-Inducing \u03b3-Irradiation. Cancer Res. 2016;76(16):4673 LP-4683.","journal-title":"Cancer Res"},{"issue":"1","key":"485_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-016-0149-6","volume":"4","author":"T Crocenzi","year":"2016","unstructured":"Crocenzi T, Cottam B, Newell P, Wolf RF, Hansen PD, Hammill C, Solhjem MC, To YY, Greathouse A, Tormoen G, Jutric Z, Young K, Bahjat KS, Gough MJ, Crittenden MR. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. J Immunother Cancer. 2016;4(1):1\u201313.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"485_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"T Zhang","year":"2017","unstructured":"Zhang T, Yu H, Ni C, Zhang T, Liu L, Lv Q, Zhang Z, Wang Z, Wu D, Wu P, Chen G, Wang L, Wei Q, Huang J, Wang X. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage i non-small-cell lung cancer. Sci Rep. 2017;7(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"13 Supplement","key":"485_CR59","first-page":"2984 LP-2984","volume":"78","author":"S Mok","year":"2018","unstructured":"Mok S, Duffy CR, Allison JP. Abstract 2984: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse. Cancer Res. 2018;78(13 Supplement):2984 LP-2984.","journal-title":"Cancer Res"},{"issue":"334","key":"485_CR60","doi-asserted-by":"publisher","first-page":"334ra52","DOI":"10.1126\/scitranslmed.aad8307","volume":"8","author":"MJ Welters","year":"2016","unstructured":"Welters MJ, van der Sluis TC, van Meir H, Loof NM, van Ham VJ, van Duikeren S, Santegoets SJ, Arens R, de Kam ML, Cohen AF, van Poelgeest MI, Kenter GG, Kroep JR, Burggraaf J, Melief CJ, van der Burg SH. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses. Sci Transl Med. 2016;8(334):334ra52.","journal-title":"Sci Transl Med"},{"issue":"5","key":"485_CR61","doi-asserted-by":"publisher","first-page":"377 LP-382","DOI":"10.1158\/2326-6066.CIR-16-0048","volume":"4","author":"R Abu Eid","year":"2016","unstructured":"Abu Eid R, Razavi GSE, Mkrtichyan M, Janik J, Khleif SN. Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed. Cancer Immunol Res. 2016;4(5):377 LP-382.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"485_CR62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","volume":"56","author":"F Ghiringhelli","year":"2007","unstructured":"Ghiringhelli F, Menard C, Puig PE, Ladoire S, Roux S, Martin F, Solary E, Le Cesne A, Zitvogel L, Chauffert B. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother. 2007;56(5):641\u20138.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"485_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00262-011-1106-3","volume":"61","author":"Y Ge","year":"2012","unstructured":"Ge Y, Domschke C, Stoiber N, Schott S, Heil J, Rom J, Blumenstein M, Thum J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F. Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome. Cancer Immunol Immunother. 2012;61(3):353\u201362.","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"485_CR64","first-page":"3689 LP-3697","volume":"61","author":"J-PH Machiels","year":"2001","unstructured":"Machiels J-PH, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Cyclophosphamide, Doxorubicin, and Paclitaxel Enhance the Antitumor Immune Response of Granulocyte\/Macrophage-Colony Stimulating Factor-secreting Whole-Cell Vaccines in HER-2\/neu Tolerized Mice. Cancer Res. 2001;61(9):3689 LP-3697.","journal-title":"Cancer Res"},{"issue":"12","key":"485_CR65","doi-asserted-by":"publisher","first-page":"2691 LP-2702","DOI":"10.1084\/jem.20061104","volume":"203","author":"P Serafini","year":"2006","unstructured":"Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, Dolcetti L, Bronte V, Borrello I. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med. 2006;203(12):2691 LP-2702.","journal-title":"J Exp Med"},{"issue":"1","key":"485_CR66","doi-asserted-by":"publisher","first-page":"39 LP-48","DOI":"10.1158\/1078-0432.CCR-14-1711","volume":"21","author":"DT Weed","year":"2015","unstructured":"Weed DT, Vella JL, Reis IM, De la fuente AC, Gomez C, Sargi Z, Nazarian R, Califano J, Borrello I, Serafini P. Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015;21(1):39 LP-48.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"485_CR67","doi-asserted-by":"publisher","first-page":"567 LP-572","DOI":"10.4049\/jimmunol.176.1.567","volume":"176","author":"JC Hoyt","year":"2006","unstructured":"Hoyt JC, Ballering J, Numanami H, Hayden JM, Robbins RA. Doxycycline Modulates Nitric Oxide Production in Murine Lung Epithelial Cells. J Immunol. 2006;176(1):567 LP-572.","journal-title":"J Immunol"},{"key":"485_CR68","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","DOI":"10.1093\/nar\/gkv007"},{"key":"485_CR69","doi-asserted-by":"crossref","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, Fr\u00f6hling S, Chan EM, Sos ML, Michel K, Mermel C, Silver SJ, Weir BA, Reiling JH, Sheng Q, Gupta PB, Wadlow RC, Le H, Hoersch S, Wittner BS, Ramaswamy S, Livingston DM, Sabatini DM, Meyerson M, Thomas RK, Lander ES, Mesirov JP, Root DE, Gilliland DG, Jacks T, Hahn WC. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108-12.","DOI":"10.1038\/nature08460"},{"key":"485_CR70","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7.","DOI":"10.1186\/1471-2105-14-7"}],"updated-by":[{"DOI":"10.1136\/jitc-2020-0485-9corr","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000}}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-018-0485-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0485-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:44:05Z","timestamp":1601055845000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-018-0485-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s40425-018-0485-9","relation":{"correction":[{"id-type":"doi","id":"10.1136\/jitc-2020-0485-9corr","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"4 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All mice were housed and treated in accordance with Institutional Animal Care and Use Committee guidelines at Baylor College of Medicine. Patients were involved after signing informed consent and studies were conducted in accordance with the Declaration of Helsinki and approved by the local medical ethical committee of the Leiden University Medical Center (LUMC) and in agreement with the Dutch law.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.D.G. has received travel support from PerkinElmer. A.G.S. receives support in the form of investigational drug from Advaxis for an investigator-initiated clinical trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}